2022
DOI: 10.1101/2022.05.18.492567
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

Abstract: Centrosome amplification (CA) is a hallmark of cancer that is strongly associated with highly aggressive disease and worse clinical outcome. However, there are no effective strategies targeting cancer cells with CA while sparing normal cells. Here, we identified Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) to be overexpressed in tumors with CA, and its high expression is associated with dramatically worse clinical outcome. We demonstrated that TACC3 forms distinct functional interactions in mit… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 65 publications
1
0
0
Order By: Relevance
“…As reported previously (33,34), centrioles are remarkably overduplicated in breast cancer cells such as MDA-MB-436, MDA-MB-231, SKBR3 and HCC1806 cells, but not in the spontaneously immortalized, non-malignant breast cell line MCF10A (Figure 2A). In particular, centriole 8 / 45 overduplication was found to be particularly severe in the MDA-MB-436 line (approximately 80%) (Figure 1B and Figure 2B), suggesting that it CEP44 may play critical role in regulating centriole duplication in breast cancer cells.…”
Section: Cep44 Is a Negative Regulator Of Centriole Duplicationsupporting
confidence: 82%
“…As reported previously (33,34), centrioles are remarkably overduplicated in breast cancer cells such as MDA-MB-436, MDA-MB-231, SKBR3 and HCC1806 cells, but not in the spontaneously immortalized, non-malignant breast cell line MCF10A (Figure 2A). In particular, centriole 8 / 45 overduplication was found to be particularly severe in the MDA-MB-436 line (approximately 80%) (Figure 1B and Figure 2B), suggesting that it CEP44 may play critical role in regulating centriole duplication in breast cancer cells.…”
Section: Cep44 Is a Negative Regulator Of Centriole Duplicationsupporting
confidence: 82%